Profund Advisors’s Novavax NVAX Stock Holding History

Profund Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$903K	Sell	110,955 -10,738	-9%	-$97.3K	0.03%	375
2025 Q4	$818K	Buy	121,693 +65,631	+117%	+$495K	0.02%	405
2025 Q3	$486K	Buy	56,062 +2,769	+5%	+$21.6K	0.02%	520
2025 Q2	$336K	Sell	53,293 -4,543	-8%	-$30.1K	0.01%	635
2025 Q1	$371K	Sell	57,836 -11,377	-16%	-$94K	0.02%	578
2024 Q4	$556K	Sell	69,213 -4,755	-6%	-$45.8K	0.02%	464
2024 Q3	$934K	Buy	73,968 +24,655	+50%	+$318K	0.04%	340
2024 Q2	$624K	Sell	49,313 -207,745	-81%	-$2.09M	0.02%	426
2024 Q1	$1.23M	Buy	257,058 +407	+0.2%	+$1.89K	0.05%	304
2023 Q4	$1.23M	Buy	256,651 +91,857	+56%	+$562K	0.05%	288
2023 Q3	$1.19M	Sell	164,794 -34,389	-17%	-$275K	0.07%	244
2023 Q2	$1.48M	Buy	199,183 +9,542	+5%	+$75K	0.08%	212
2023 Q1	$1.31M	Buy	+189,641	New	+$1.74M	0.08%	224
2022 Q3	–	Sell	-8,928	Closed	-$459K	–	991
2022 Q2	$459K	Sell	8,928 -491	-5%	-$25.4K	0.03%	453
2022 Q1	$694K	Sell	9,419 -977	-9%	-$87.1K	0.03%	423
2021 Q4	$1.49M	Sell	10,396 -1,682	-14%	-$289K	0.05%	242
2021 Q3	$2.5M	Buy	12,078 +444	+4%	+$97.9K	0.08%	187
2021 Q2	$2.47M	Sell	11,634 -2,220	-16%	-$407K	0.08%	195
2021 Q1	$2.51M	Buy	13,854 +607	+5%	+$121K	0.1%	176
2020 Q4	$1.48M	Buy	13,247 +1,671	+14%	+$178K	0.06%	238
2020 Q3	$1.25M	Buy	+11,576	New	+$1.41M	0.06%	237
2019 Q1	–	Sell	-561	Closed	-$21K	–	1229
2018 Q4	$21K	Sell	561 -217	-28%	-$8.41K	﹤0.01%	1142
2018 Q3	$29K	Hold	778	–	–	﹤0.01%	1543
2018 Q2	$21K	Buy	778 +8	+1%	+$270	﹤0.01%	1489
2018 Q1	$32K	Hold	770	–	–	﹤0.01%	1473
2017 Q4	$19K	Buy	770 +103	+15%	+$2.51K	﹤0.01%	1452
2017 Q3	$15K	Sell	667 -5,372	-89%	-$120K	﹤0.01%	1432
2017 Q2	$139K	Buy	6,039 +23	+0.4%	+$451	0.01%	1378
2017 Q1	$154K	Sell	6,016 -519	-8%	-$14.3K	0.01%	1411
2016 Q4	$165K	Sell	6,535 -887	-12%	-$25.9K	0.01%	1491
2016 Q3	$309K	Sell	7,422 -225	-3%	-$29K	0.01%	1073
2016 Q2	$1.11M	Sell	7,647 -323	-4%	-$37K	0.05%	340
2016 Q1	$823K	Sell	7,970 -1,868	-19%	-$200K	0.04%	436
2015 Q4	$1.65M	Sell	9,838 -20	-0.2%	-$3.08K	0.08%	199
2015 Q3	$1.39M	Buy	+9,858	New	+$2.21M	0.08%	204
2014 Q3	–	Sell	-860	Closed	-$79K	–	1413
2014 Q2	$79K	Buy	860 +50	+6%	+$4.39K	﹤0.01%	1505
2014 Q1	$73K	Buy	+810	New	+$90.5K	﹤0.01%	1539

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Profund Advisors's NVAX Position: Q1 2026 in Review

Profund Advisors reduced its Novavax (NVAX) stake by 8.8% in Q1 2026, selling an estimated $97.3K and leaving 110,955 shares worth $903K. The position accounts for 0.03% of the portfolio, ranked #375.

Profund Advisors first reported a position in NVAX in Q1 2014 and has held it in 37 quarters since. The position peaked at $2.51M in Q1 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

Profund Advisors held 110,955 shares of Novavax worth $903K as of Q1 2026.
Profund Advisors sold 10,738 Novavax shares in Q1 2026, an estimated $97.3K.
Novavax made up 0.03% of Profund Advisors's portfolio in Q1 2026, its #375 holding.
Profund Advisors first reported a position in Novavax in Q1 2014 and has held it in 37 quarters since.
Profund Advisors's Novavax position peaked at $2.51M in Q1 2021.
257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Profund Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.